Azafaros BV, of Leiden, the Netherlands, appointed Kyle Landskroner head of preclinical drug development, Ruben Giorgino head of clinical research and development and Louise Kooij head of finance and operations.
Confo Therapeutics NV, of Ghent, Belgium, appointed Rob Scott to its board.
Gritstone Oncology Inc., of Emeryville, Calif., appointed Jean-Charles Soria to its scientific advisory board.
Legend Biotech Corp., of Somerset, N.J., appointed Corazon Dating Sanders, Darren Ji and Philip Yau to its board.
Oric Pharmaceuticals Inc., of South San Francisco, appointed Lori Kunkel to its board.
Tonix Pharmaceuticals Holding Corp., of New York, appointed Richard H. Bagger to its board.
Verrica Pharmaceuticals Inc., of West Chester, Pa., appointed Diem Nguyen to its board.